Medical Marijuana Vs Opioids — How Medical Marijuana Affects the Opioid Crises

Medical Marijuana Vs Opioids — Medical Marijuana is Being Studied by Scientists in the Hopes of fighting America’s Ongoing Opioid Crisis

UCLA is home to one of the first academic programs worldwide dedicated to studying marijuana and opioids. The university is conducting a focused study into how medical marijuana affects the opioid crises

A distinguished professor of psychiatry and pharmacology at the UCLA School of Medicine, Edythe London, is the creator of the study

She explained that it will test various combinations of Tetrahydrocannabinol (THC), and cannabidiol (CBD) to determine whether or not they can be utilized for the treatment of opioid addiction.

During an interview with NBC News, London explained that the study will focus on which combinations are most effective at reducing the patient’s use of opioids while relieving their pain.

Director of the Cannabis Research Institute, Dr. Jeffrey Chen believes that research on medical marijuana lags behind where it should be in 2018.

“The public consumption of cannabis has already far outpaced our scientific understanding. We really desperately need to catch up.”

Medical Marijuana Vs Opioids For Treatment of Chronic Pain

Robby Pinnamaneni has been suffering from chronic pain since he was involved in a serious car accident that resulted in broken bones and nerve damage. He explained that he refused to use opioids because of their addictive properties.

“I turned to cannabis in lieu of pills and I’ve never turned back.”

Pinnamaneni and Alex Jordan, another individual who also suffers from chronic pain are employees of Triple Seven, a marijuana dispensary in Los Angeles.

Pinnamaneni stated that the average age of the customers at their stores is 40 to 45.

“I see families that come in together and shop for pain relief. I think people are opening their eyes to the fact that this isn’t some evil drug.”

Lower Opioid Use in States With Medical Marijuana

In one of two, five-year longitudinal studies published in the Journal of the American Medical Association’s (JAMA) Internal Medicine, it has been discovered that the states that have legalized medical marijuana have fewer opioid prescriptions being filled.

However, the study was unable to establish whether the opioid users were switching to medical marijuana.

A health policy analyst at the University of California, San Diego, Yuyan Shi, stated that medical marijuana has shown promise in being able to reduce opioid use and addiction.

Shi believes that the research is needed into the topic.

However, before the research can begin approval needs to be granted by the Food and Drug Administration and the Drug Enforcement Administration, along with funding.